B6.Cg-Tg(Thy1-SERPINI1*S52R)794Zbz/Biat

Status

Available to order

EMMA IDEM:11490
Citation informationRRID:IMSR_EM:11490 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Tg(Thy1-SERPINI1*S52R)794Zbz/Biat
Alternative nameHuman S52R-Portland mutated neuroserpin
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Thy1-SERPINI1*S52R)794Zbz
Gene/Transgene symbolTg(Thy1-SERPINI1*S52R)794Zbz

Information from provider

ProviderThomas Rülicke
Provider affiliationBiomedical Sciences, University of Veterinary Medicine
Genetic informationTransgenic mice overexpressing human neuroserpin with the S52R-Portland mutation under the control of the Thy1 promoter were generated by pronuclear injection into fertilized oocytes using an expression cassette derived from the murine Thy1 gene. The S52R-Portland mutation was introduced into the human neuroserpin cDNA using the polymerase chain reaction technique. The transgene was expressed in central nervous system neurons throughout postnatal life. The expression levels for transgenic mice with human Portland neuroserpin is 3.3 times [line Tg(NSS52R)794Zbz] above the endogenous neuroserpin level of wild-type mice.
Phenotypic informationHomozygous:
unknown

Heterozygous:
Transgenic mice appeared healthy at birth, developed normally, and did not exhibit any obvious neurological or behavioral abnormalities during early adulthood. However, at 17 and 21 months of age the Portland line 794 mice began to exhibit severe neurological symptoms and behavioral abnormalities, reminiscent of those found in familial encephalopathy with neuroserpin inclusion bodies (FENIB) patients. They developed severe ataxia, moved slowly with staggering gait, were incapable of grasping a horizontal wire and climbing a grid of negative geotaxis, and exhibited a considerably greater passivity during handling. In addition, mice overexpressing Portland neuroserpin showed tremor and seizure-like episodes.
Breeding historyThe transgenic lines were generated on a B6D2F2 hybrid background and backcrossed to C57BL/6J for at least 10 generations.
ReferencesNone available
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivingheterozygous Other (please specify below) males

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).